Lindbrook Capital’s Collegium Pharmaceutical COLL Stock Holding History

Lindbrook Capital’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$149	Buy	+5	New	+$153	﹤0.01%	2728
2024 Q4	–	Sell	-2	Closed	-$77	–	2801
2024 Q3	$77	Buy	+2	New	+$71	﹤0.01%	2794
2022 Q3	–	Sell	-104	Closed	-$1.83K	–	2659
2022 Q2	$2K	Sell	104 -77	-43%	-$1.29K	﹤0.01%	1927
2022 Q1	$4K	Buy	+181	New	+$3.42K	﹤0.01%	1682

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Lindbrook Capital's COLL Position: Q1 2025 in Review

Lindbrook Capital opened a new position in Collegium Pharmaceutical (COLL) in Q1 2025: 5 shares worth $149. The stake represents ﹤0.01% of the portfolio and ranks #2728 among its holdings. This is a return to the name: Lindbrook Capital previously reported a position in COLL as recently as Q3 2024.

Lindbrook Capital first reported a position in COLL in Q1 2022 and has held it in 4 quarters since. The position peaked at $4K in Q1 2022. 242 funds tracked by Wall St. Rank hold COLL as of Q1 2025.

Lindbrook Capital held 5 shares of Collegium Pharmaceutical worth $149 as of Q1 2025.
Collegium Pharmaceutical was a new Lindbrook Capital position in Q1 2025.
Collegium Pharmaceutical made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2728 holding.
Lindbrook Capital first reported a position in Collegium Pharmaceutical in Q1 2022 and has held it in 4 quarters since.
Lindbrook Capital's Collegium Pharmaceutical position peaked at $4K in Q1 2022.
242 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.